Indus Officially Acquires Olympus Therapeutics Pvt. Ltd., India

Indus is pleased to announce the official acquisition of Olympus Therapeutics Pvt. Ltd., marking a significant milestone in Indus’ strategic expansion into the India market.

This acquisition represents Indus’ formal entry into India, one of the world’s most dynamic and rapidly growing pharmaceutical markets. With this step, Indus strengthens its global footprint while reinforcing its long-term commitment to innovation, quality, and patient-centric healthcare solutions.

Olympus Therapeutics brings with it a strong and well-established presence in Gynecology and Infertility specialties, supported by deep clinical expertise, trusted brands, and long-standing relationships with healthcare professionals across India.

Following the acquisition, Indus has also launched a new dedicated Hera division focused on Dermatology and Cosmetology, expanding its therapeutic reach into high-growth specialty segments. This new division will leverage Indus’ global expertise and Olympus’ local market strength to deliver advanced, science-backed solutions for dermatologists and aesthetic practitioners.

Together, Indus and Olympus Therapeutics are poised to create synergistic growth, strengthen specialty leadership, and enhance access to differentiated healthcare solutions for patients and healthcare professionals across India.